PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 178 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $50,000 | -23.1% | 7,106 | 0.0% | 0.00% | – |
Q2 2021 | $65,000 | -5.8% | 7,106 | 0.0% | 0.00% | – |
Q1 2021 | $69,000 | -5.5% | 7,106 | 0.0% | 0.00% | – |
Q4 2020 | $73,000 | +1.4% | 7,106 | 0.0% | 0.00% | – |
Q3 2020 | $72,000 | -2.7% | 7,106 | 0.0% | 0.00% | – |
Q2 2020 | $74,000 | +23.3% | 7,106 | 0.0% | 0.00% | – |
Q1 2020 | $60,000 | +13.2% | 7,106 | +16.8% | 0.00% | – |
Q4 2019 | $53,000 | -19.7% | 6,086 | 0.0% | 0.00% | – |
Q3 2019 | $66,000 | -14.3% | 6,086 | 0.0% | 0.00% | – |
Q2 2019 | $77,000 | -67.4% | 6,086 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $236,000 | +90.3% | 6,086 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $124,000 | -55.6% | 6,086 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $279,000 | -22.5% | 6,086 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $360,000 | -13.0% | 6,086 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $414,000 | -35.3% | 6,086 | -5.9% | 0.00% | -25.0% |
Q4 2017 | $640,000 | -17.4% | 6,471 | 0.0% | 0.00% | -33.3% |
Q3 2017 | $775,000 | +36.9% | 6,471 | 0.0% | 0.01% | +50.0% |
Q2 2017 | $566,000 | +134.9% | 6,471 | 0.0% | 0.00% | +100.0% |
Q1 2017 | $241,000 | +21.1% | 6,471 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $199,000 | -54.1% | 6,471 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $434,000 | +124.9% | 6,471 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $193,000 | -9.8% | 6,471 | -11.0% | 0.00% | 0.0% |
Q1 2016 | $214,000 | -62.5% | 7,274 | -0.0% | 0.00% | -60.0% |
Q4 2015 | $570,000 | +4.0% | 7,275 | +0.1% | 0.01% | 0.0% |
Q3 2015 | $548,000 | -35.5% | 7,268 | -0.1% | 0.01% | -28.6% |
Q2 2015 | $850,000 | -44.4% | 7,277 | +12.5% | 0.01% | -46.2% |
Q1 2015 | $1,528,000 | +24.7% | 6,471 | 0.0% | 0.01% | +30.0% |
Q4 2014 | $1,225,000 | -20.7% | 6,471 | 0.0% | 0.01% | -23.1% |
Q3 2014 | $1,544,000 | +119.6% | 6,471 | -39.2% | 0.01% | +116.7% |
Q2 2014 | $703,000 | – | 10,651 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |